Viana-Rojas Jesús Antonio, Argaiz Eduardo, Robles-Ledesma Mariana, Arias-Mendoza Alexandra, Nájera-Rojas Nitzha Andrea, Alonso-Bringas Alma Paola, De Los Ríos-Arce Luis Fernando, Armenta-Rodriguez Jennifer, Gopar-Nieto Rodrigo, Briseño-De la Cruz Jose Luis, González-Pacheco Héctor, Sierra-Lara Martinez Daniel, Gonzalez-Salido Jimena, Lopez-Gil Salvador, Araiza-Garaygordobil Diego
Coronary Care Unit, Instituto Nacional de Cardiología 'Ignacio Chávez', Juan Badiano 1, Belisario Domínguez Sección XVI, Tlalpan, 14030 Mexico City, México.
Tecnológico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, México.
Eur Heart J Acute Cardiovasc Care. 2023 Jul 7;12(7):413-419. doi: 10.1093/ehjacc/zuad048.
Systemic venous congestion is associated with an increased risk of acute kidney injury (AKI) in critically ill patients. Venous Excess Ultrasound Score (VExUS) has been proposed as a non-invasive score to assess systemic venous congestion. We aimed to evaluate the association between VExUS and AKI in patients with acute coronary syndrome (ACS).
This is a prospective study including patients with the diagnosis of ACS (both ST elevation and non-ST elevation ACS). VExUS was performed during the first 24 h of hospital stay. Patients were classified according to the presence of systemic congestion (VExUS 0/≥1). The primary objective of the study was to determine the occurrence of AKI, defined by KDIGO criteria. A total of 77 patients were included. After ultrasound assessment, 31 (40.2%) patients were categorized as VExUS ≥1. VExUS ≥1 was more frequently found in inferior vs. anterior myocardial infarction/non-ST-segment elevation acute myocardial infarction (48.3 vs. 25.8 and 22.5%, P = 0.031). At each increasing degree of VExUS, a higher proportion of patients developed AKI: VExUS = 0 (10.8%), VExUS = 1 (23.8%), VExUS = 2 (75.0%), and VExUS = 3 (100%; P < 0.001). A significant association between VExUS ≥1 and AKI was found [odds ratio (OR): 6.75, 95% confidence interval (CI): 2.21-23.7, P = 0.001]. After multivariable analysis, only VExUS ≥1 (OR: 6.15; 95% CI: 1.26-29.94, P = 0.02) remained significantly associated with AKI.
In patients hospitalized with ACS, VExUS is associated with the occurrence of AKI. Further studies are needed to clarify the role of VExUS assessment in patients with ACS.
在危重症患者中,全身静脉淤血与急性肾损伤(AKI)风险增加相关。静脉过量超声评分(VExUS)已被提议作为评估全身静脉淤血的一种非侵入性评分。我们旨在评估急性冠脉综合征(ACS)患者中VExUS与AKI之间的关联。
这是一项前瞻性研究,纳入诊断为ACS(包括ST段抬高型和非ST段抬高型ACS)的患者。在住院的头24小时内进行VExUS检查。根据是否存在全身淤血(VExUS 0/≥1)对患者进行分类。该研究的主要目的是确定按照KDIGO标准定义的AKI的发生情况。共纳入77例患者。超声评估后,31例(40.2%)患者被归类为VExUS≥1。下壁心肌梗死/非ST段抬高型急性心肌梗死患者中VExUS≥1更为常见(分别为48.3%、25.8%和22.5%,P = 0.031)。随着VExUS程度的增加,发生AKI的患者比例更高:VExUS = 0(10.8%),VExUS = 1(23.8%),VExUS = 2(75.0%),VExUS = 3(100%;P < 0.001)。发现VExUS≥1与AKI之间存在显著关联[比值比(OR):6.75,95%置信区间(CI):2.21 - 23.7,P = 0.001]。多变量分析后,只有VExUS≥1(OR:6.15;95% CI:1.26 - 29.94,P = 0.02)仍与AKI显著相关。
在因ACS住院的患者中,VExUS与AKI的发生相关。需要进一步研究以阐明VExUS评估在ACS患者中的作用。